Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander R Moschen

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
BMJ Open Gastroenterology|February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitisEdouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research|April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitisJae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Ethanol-mediated suppression of IL-37 licenses alcoholic liver diseaseFelix Grabherr, Christoph Grander, Timon E Adolph, et al.
Scandinavian Journal of Gastroenterology|December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitisAxel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Leukemia|January 25, 2020
Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activityRomana R Gerner, Sophie Macheiner, Simon Reider, et al.
Ebiomedicine|August 14, 2021
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19Andreas Zollner, Christina Watschinger, Annika Rössler, et al.
Gut|July 24, 2020
Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humansChristoph Grander, Benedikt Schaefer, Julian Schwärzler, et al.
Gastroenterology|July 17, 2007
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reactionMichelle M Richardson, Julie R Jonsson, Elizabeth E Powell, et al.
Cell Host & Microbe|April 15, 2016
Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota AlterationsAlexander R Moschen, Romana R Gerner, Jun Wang, et al.
Diabetes|December 1, 2016
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 DiabetesPeter Willeit, Philipp Skroblin, Alexander R Moschen, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
BMJ Open Gastroenterology|February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitisEdouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research|April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitisJae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Ethanol-mediated suppression of IL-37 licenses alcoholic liver diseaseFelix Grabherr, Christoph Grander, Timon E Adolph, et al.
Scandinavian Journal of Gastroenterology|December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitisAxel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Leukemia|January 25, 2020
Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activityRomana R Gerner, Sophie Macheiner, Simon Reider, et al.
Ebiomedicine|August 14, 2021
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19Andreas Zollner, Christina Watschinger, Annika Rössler, et al.
Gut|July 24, 2020
Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humansChristoph Grander, Benedikt Schaefer, Julian Schwärzler, et al.
Gastroenterology|July 17, 2007
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reactionMichelle M Richardson, Julie R Jonsson, Elizabeth E Powell, et al.
Cell Host & Microbe|April 15, 2016
Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota AlterationsAlexander R Moschen, Romana R Gerner, Jun Wang, et al.
Diabetes|December 1, 2016
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 DiabetesPeter Willeit, Philipp Skroblin, Alexander R Moschen, et al.
Pageof 10